Former CEO and company chairman Brad Nutter announces retirement from the Braintree, Mass.-based blood management company after seven years. Brad Nutter, the turnaround artist who helped pump new life into Haemonetics Corp. (NYSE:HAE) as CEO and later chairman of the board, said he will retire from the company’s board of directors effective November 1, 2010. […]
Founded in 1999, CHF’s core technology is the Aquadex FlexFlow System, a device that removes excess fluids, primarily water, from the blood of patients suffering from congestive heart failure, renal failure, metabolic diseases and post-surgery complications.
Gabby Everett, the site director for BioLabs Pegasus Park, offered a tour of the space and shared some examples of why early-stage life science companies should choose North Texas.